The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcome comparison of once versus twice daily dosing of zanubrutinib.
 
Allison Kagerer
No Relationships to Disclose
 
Hannah Farnworth
No Relationships to Disclose
 
Theresia Akhlaghi
No Relationships to Disclose
 
Zhengming Chen
No Relationships to Disclose
 
Erin Mulvey
No Relationships to Disclose
 
Richard Furman
Honoraria - AstraZeneca; BeiGene; Janssen
Consulting or Advisory Role - Abbvie; Acerta Pharma; AstraZeneca; BeiGene; Genentech/Roche; Incyte; Janssen Biotech; Loxo; MEI Pharma; MorphoSys; OncoTracker; Pharmacyclics; Sanofi; TG Therapeutics; Verastem; X4 Pharma
Research Funding - Acerta Pharma; TG Therapeutics
Expert Testimony - Abbvie; Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology; TG Therapeutics
Other Relationship - Incyte; Janssen Biotech
 
John Allan
Honoraria - Abbvie; AstraZeneca; BeiGene; Pharmacyclics/Janssen
Consulting or Advisory Role - Abbvie/Genentech; ADC Therapeutics; Ascentage Pharma; BeiGene; Janssen Oncology; Pharmacyclics; TG Therapeutics
Research Funding - Celgene; Genentech; Janssen; TG Therapeutics